MEDICO REMEDIES             
           | 
        |
| BOM : 540937     NSE : MEDICO     | |
|    LT :                             
               
                
                
                                      
                                    
                
                
                    Long Term Analysis   
              
                
                
              
                     Fundamentals : Average 
                             
                  
              Valuation : Bad [Stock is Expensive] Debt : Low  | 
              Updated: | 
| ST :                              
                 
                  
                  
                  
                       Short Term Analysis   
                
                      
                    
          
                   
                       Quarterly Earnings Trend : Neutral 
                               
                    
                Price Momentum : Mild Upward Pledged Shares : None or < 25%  | 
                  Nov 04,2025 | 
| 
            Price(EOD): ₹ 50.49               
                  
                  
                  This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
                  
                    
            
             | 
            Pharmaceuticals & Drugs | 
| MCap: ₹ 419.07 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y | 
| MEDICO REMEDIES | 1.1% | 3.3% | -11.4% | 
| SUN PHARMACEUTICAL INDUSTRIES | 1.2% | 4.4% | -9.7% | 
| DIVIS LABORATORIES | 5.8% | 19.2% | 16.3% | 
| CIPLA | -3.7% | -0.2% | 1.6% | 
| TORRENT PHARMACEUTICALS | 1.4% | 1.8% | 10.8% | 
| DR REDDYS LABORATORIES | -7.3% | -4% | -6.1% | 
| MANKIND PHARMA | -0.1% | -1.5% | -5.7% | 
| ZYDUS LIFESCIENCES | -2.1% | -1.1% | -2.8% | 
| LUPIN | 3.4% | 0.2% | -11% | 
FUNDAMENTAL ANALYSIS OF MEDICO REMEDIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF MEDICO REMEDIES
 | Ratio | Standalone | |
|---|---|---|
| 
               P/E   P/B P/S  |  
                                
                40.56                   
                      
                      P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 10.33 Cr 
                [Latest Qtr - Jun2025 - Standalone Results ] 6.71 
                      
                      P/B Calculated based on Book Value of Rs 62.47 Cr  
                [Latest Year - Mar2025 - Standalone Results ] 2.65 
                      
                      P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr  
                [Latest Qtr - Jun2025 - Standalone Results ]  | 
              |
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+)  | 
          
|---|---|
| 
          EV/EBIDTA EV/Sales Price/Sales  | 
          
          201%  466% 283%  | 
          
SHARE PRICE MOMENTUM OF MEDICO REMEDIES
MEDICO REMEDIES vs SENSEX
DEBT OF MEDICO REMEDIES
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
| 
                        2025 2024 2023 Avg_3yrs  | 
                        
                        0.22  0.13 0.18 0.18  | 
                        
                  
                  
                  -  - - -  | 
                  
| 
                          [Last Annual Data : Mar2025]    
                       | 
                  ||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF MEDICO REMEDIES
| Pledged Promoter Shares  | 
          
            
          
          0 % | |
|---|---|---|
| As on : Sep2025 | ||
If less than 25%  |    Good  | 
      
          |
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF MEDICO REMEDIES
| Standalone | Q-o-Q | Y-o-Y | 
|---|---|---|
| 
          Revenue Op Profit Profit Before Tax Profit After Tax  | 
          
           -7.39% -57.59% -57.28% -58.1%  | 
          
           24.2% 0.57% 11.91% 15.14%  | 
|  QtrlyTrend | 
            0 | |
| Latest Qtr: Jun2025 | ||
| Quarterly Result Analysis → | ||
MEDICO REMEDIES related INDICES
You may also like the below Video Courses
FAQ about MEDICO REMEDIES
Is MEDICO REMEDIES good for long term investment?
As on Nov 04,2025, the Fundamentals of MEDICO REMEDIES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of MEDICO REMEDIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is MEDICO REMEDIES UnderValued or OverValued?
As on Nov 04,2025, MEDICO REMEDIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of MEDICO REMEDIES ?
As on Nov 04,2025, the Intrinsic Value of MEDICO REMEDIES is Rs. 13.18 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 16.78
Fair Value [Median EV / Sales Model] : Rs. 8.92
Fair Value [Median Price / Sales Model] : Rs. 13.18
Estimated Median Fair Value of MEDICO REMEDIES : Rs. 13.18
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.